Eckert & Ziegler SE

EUZ

DE0005659700

Office Equipment

Real-time Estimate Tradegate Other stock markets 07:34:29 2024-05-29 EDT			5-day change	1st Jan Change
44.11 ^EUR	-1.28%		-4.20%	+7.02%

05-15	ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	ZD
05-14	Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating

May 15, 2024 at 07:49 am

Alexander Galitsa from Hauck & Aufhauser retains his positive opinion on the stock with a Buy rating. The target price is increased from EUR 60.00 to EUR 62.50.

Latest news about Eckert & Ziegler SE

ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	05-15	ZD
Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
ECKERT & ZIEGLER : Hauck & Aufhauser maintains a Buy rating	04-24	ZD
Eckert & Ziegler increases profit at the start of the year - targets confirmed	04-22	DP
Eckert & Ziegler SE Reaffirms Earnings Guidance for the Year 2024	04-22	CI
RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals	04-04	CI
Transcript : Eckert & Ziegler Strahlen- und Medizintechnik AG, 2023 Earnings Call, Mar 22, 2024	03-22
Eckert & Ziegler SE Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
Eckert & Ziegler recovers - Dividend disappointed - 'Balance sheet strong'	03-20	DP
Eckert & Ziegler cuts dividend in favor of investments	03-20	DP
ECKERT & ZIEGLER : Receives a Buy rating from Hauck & Aufhauser	03-20	ZD
Eckert & Ziegler plans further growth - dividend decreases significantly	03-19	DP
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX Index (Price Return)	03-17	CI
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX (Total Return) Index	03-17	CI
Deutsche Börse's Stoxx to Make Changes to DAX Indices	03-06	MT
Index changes move - MDax ejection weighs on Rational	03-06	DP
ECKERT & ZIEGLER : Gets a Buy rating from Hauck & Aufhauser	03-06	ZD
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177	01-31	CI
ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating	01-03	ZD
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	12-07	ZD
Chairman of the Supervisory Board of Eckert & Ziegler moves to subsidiary Pentixapharm	11-21	DP
Eckert & Ziegler AG Announces Executive Changes	11-21	CI
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	11-20	ZD
Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	11-08	ZD

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Sector

Office Equipment

Calendar

2024-05-28 - Ex-dividend day for final dividend

More about the company

Income Statement Evolution

More financial data

Ratings for Eckert & Ziegler SE

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

44.68 EUR

Average target price

62.5 EUR

Spread / Average Target

+39.88%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
ECKERT & ZIEGLER SE	+7.02%	1.01B
SHIMADZU CORPORATION	+4.62%	7.97B
TECAN GROUP AG	-6.17%	4.52B
OLINK HOLDING AB	-4.49%	2.99B
JEOL LTD.	+5.65%	2.14B
NINGBO YONGXIN OPTICS CO.,LTD	-32.79%	1.02B
PARK SYSTEMS CORP.	+0.46%	889M
MLOPTIC CORP.	-48.06%	821M
FOCUSED PHOTONICS (HANGZHOU), INC.	-30.41%	683M
PHENIX OPTICAL COMPANY LIMITED	-26.23%	657M

Scientific & Precision Equipment

Eckert & Ziegler SE

Equities

EUZ

DE0005659700

Office Equipment

ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating

Latest news about Eckert & Ziegler SE

Chart Eckert & Ziegler SE

Company Profile

Income Statement Evolution

Ratings for Eckert & Ziegler SE

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Scientific & Precision Equipment